Sotalol Hydrochloride Tablet
Product Images NDC 82804-951

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 82804-951). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Age About 2 Years Or Younger (Age Factor)

FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
Analysis of recurrence-free survival data comparing oral sotalol with placebo at different dosages. The p-values for each dosage group are as follows: 80 mg (0.325), 120 mg (0.018), and 160 mg (0.029). The lower the p-value, the stronger the evidence against the null hypothesis.*
FDA Label Image

Study 2 (Figure3)

Study 2 (Figure3)
This description is not available.*
FDA Label Image

82804-951-30 (Image 01)

82804-951-30 (Image 01)
This information pertains to Sotalol HCI 120mg tablets packaged by Proficient Rx LP. Each tablet contains 120 mg of Sotalol Hydrochloride USP and is capsule-shaped, bisected, light-blue, and scored. The tablets are imprinted with "842" on one side and "O" on the reverse side. The product ID is ZS095130. Manufactured by Oxford Pharmaceuticals, LLC in Birmingham, Alabama. It is recommended to store the medication at 20°-25°C and keep it out of the reach of children.*
FDA Label Image

Molecular Structure (Molecularstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.